Detalhe da pesquisa
1.
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity.
J Psychopharmacol;
35(2): 142-149, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33427015
2.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
J Affect Disord;
264: 527-534, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31786030
3.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
Medicine (Baltimore);
97(38): e12414, 2018 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30235716
4.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-30736